Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
Settling the conflict between public health and liberty once and for all
30/08/2020
1 Media contribution
Press/Media: Press / Media
Sara Gerke and Timo Minssen join Diana Samuel to discuss the European Commission’s white paper on artificial intelligence (published in February 2020), and the challenges of implementing the outlined approach in healthcare.
Timo Minssen & Sara Gerke
11/06/2020
1 Media contribution
Press/Media: Press / Media
Salg af vaccineproduktion har gjort os sårbare
16/03/2020
1 Media contribution
Press/Media: Press / Media
SWEDEN’s Response to COVID-19: A tale of trust, recommendations, and odorous nudges
12/05/2020
1 Media contribution
Press/Media: Press / Media
Professor: En coronavaccine skal udvikles hurtigt, men vi kan ikke slække for meget på sikkerheden
23/03/2020
1 Media contribution
Press/Media: Press / Media
Professor i sundhedsret: Er vi trygge ved at vaccineproduktion er ude af vores hænder?
19/03/2020
1 Media contribution
Press/Media: Press / Media
Preparing for Antimicrobial Resistance: Vision and Social Science Mission of the INAMRSS Network
11/12/2020
1 Media contribution
Press/Media: Press / Media
Podcast-interview: Unlocking the full potential of Open Innovation in the Life Sciences through a classification system, see: https://www.ebe-biopharma.eu/wp-content/uploads/2018/01/EBE_Open-Innovation-Podcast-3.mp3
Timo Minssen & Niclas Nilsson
14/12/2017
1 Media contribution
Press/Media: Press / Media
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2190
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published